| Hans-Günter Meyer-Thompson | NAS - Neonatales Abstinenzsyndrom
Ondansetron to reduce neonatal opioid withdrawal severity a randomized clinical trial.
Ondansetron to reduce neonatal opioid withdrawal severity a randomized clinical trial.
Peltz G, Jansson LM, Adeniyi-Jones S, Cohane C, Drover D, Shafer S, Wang M, Wu M, Govindaswami B, Jegatheesan P, Argani C, Khan S, Kraft WK.
J Perinatol. 2023 Mar;43(3):271-276. doi: 10.1038/s41372-022-01487-2. Epub 2022 Aug 27. PMID: 36030327; PMCID: PMC9968817.
Abstract